CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in NRIX — Nurix Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,215,760
+$5,893,156 QoQ
Shares Held
833,296
-9.8% QoQ
Ownership
0.803%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. NRIX ranks #68 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in NRIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,215,760 | 833,296 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,322,604 | 924,039 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,322,971 | 965,892 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,986,871 | 864,380 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,915,176 | 607,127 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,914,944 | 582,066 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $10,792,192 | 572,834 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $11,498,348 | 511,720 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,010,441 | 623,404 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,440,193 | 642,190 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $6,422,105 | 622,297 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,469,007 | 568,576 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,835,750 | 383,959 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,417,379 | 384,840 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,204,406 | 382,915 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,880,686 | 374,573 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,680,115 | 290,459 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,783,470 | 270,055 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,632,378 | 263,640 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,782,409 | 259,760 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,445,928 | 129,888 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,511,149 | 112,935 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,527,518 | 76,871 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,520,816 | 72,209 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||